REVIEW ON NOVEL ANTICANCER AGENT OF DOSTARLIMAB

• Author(s):

  S. Naveenkumar | N. Ramanathan

• Keywords:

  Dostarliamab, Malignancy, Colorectal Cancer, Endometrial Cancer,Immunotherapy, T-Cells, PD-1/PD-L1 Inhibitors, Combination Therapy.

• Abstract:

  One Of The Most Deadly Illnesses Of The 20th Century, Cancer Has Alarmingly Increased In The 21st, To The Point Where It Now Affects Every 4 People. Accordimg To GLOBOCAN 2020, There Were 19 Million New Cases Of Malignancy And Roughly 10 Million Cancer Re

---

Other Details

• Paper id:

  IJSARTV9I1274511

• Published in:

  Volume: 9 Issue: 12 December 2023

• Publication Date:

  2023-12-16

Download Article